Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.94 USD | +0.45% | +2.16% | -12.41% |
May. 10 | Bristol-Myers Squibb Says Phase 3 Trial of Opdivo in Lung Cancer Fails to Meet Primary Endpoint | MT |
May. 10 | Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint | DJ |
Filters
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company